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1. ~tr~uction 
Since 1958 the glycogen phosphorylase activity 
from mammalian uteri has been the subject’of several 
reports [l-3]. The procedures for isolation of the 
homogenous enzyme were developed later [4-61. 
Uterine enzyme was characterized as a form different 
from both liver and skeletal muscle phosphorylases 
[Z&4,5]. Here we describe an advanced procedure for 
purification of the cow uterine enzyme using AMP- 
Sepharose chromatography. Some of the characteris- 
tics of the homogenous uterine phospho~l~e, not 
previously reported, are described. The results how 
that its molecular and catalytic properties are very 
similar to those of the phosphorylase isozyme I. Part 
of this work was reported in [7]. 
2. Materials and methods 
Swine liver glycogen and Tris were obtained from 
Olaine, USSR. Glc-1 -P, Glc-6-P and AMP were pur- 
chased from Reanal, Hungary; mercaptoethanol was 
from Serva and ~-~ycerophosphate from Fluka AG. 
AMP-Sepharose was a generous gift of Pharmacia Fine 
Chemicals. All other chemicals were of highest grade 
obtainable. u-Aminohexyl-Sepharose 4B with 1.3 
equiv./ml of waminohexyl groups was prepared as in 
[8]. A modified Cori’s assay was used to measure the 
phospho~lase activity [9]. The reaction mixture con- 
tained 20 mM &glycerophosphate, 1% glycogen, 
16 mM Glc-1 -P and 1 mM AMP. Phosphorylase units 
Abbreviations: Glc-l-P,glucose-l-phosphate;Gled-P, glucose- 
6~hosphate;Pi, inorganic phosphate; PLP, pyridoxal-S’-phos- 
phate 
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were measured as tmol Pi/mm at 30°C and pH 6.8. 
Protein concentration was determined either according 
to [IO] or by direct measurement of AZse, using the 
phosphorylase index J!?:%&, = 13.2 [ 111. Enzyme 
fractions were concentrated by ultrafiltration (Diaflo 
cell, Amicon, with XM 100 filter). PLP was determined 
as in [ 121, using a Pye Unicam SP 8000 spectropho- 
tometer. Analytical isoelectric focusing was done in 
an LKB column, model 8101. 
3, Results and discussion 
Here we used the procedure described [6] for isola- 
tion of homogenous phosphorylase b from cow 
myometrium but modified at the final stage. The 
method used previously involved affinity adsorbtion 
on ~~-molec~~-wei~t glycogen in a batch pro- 
cedure, column hydrophobic hromatography and, 
finally, column chromatography on glycogen- 
hydrazidosuccinyl-Sepharose. H re, the immobilized 
glycogen was replaced by another afftity adsorbent, 
commercial AMP-Sepharose. The suspension (10 mg 
protein) was applied to a column of UP-~pharo~ 
(5 X 1.2 cm) equilibrated with 50 mM Tris-HCl/ 
1 mM EDTA/O. 1 mM-mercaptoethanol (pH 7). The 
column was then developed with the same buffer plus 
10 mM Glc-6-P. The dialysed homogenous prepara- 
tion of 1.2 mg phospho~l~ b was purified -2500- 
fold, as compared to the initial extract and the 
recovery was -7%. The specific activity of the enzyme 
was 16.5 units/mg protein at 16 mM Glc-1 -P. A typi- 
cal elution pattern is depicted in fig.1, 
AMP-Sepharose, synthesized by immobilization 
of pe~odate~~d~ed AMP on hydr~doadip~yl- 
Sepharose, was an ineffective adsorbent of uterine 
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Fig.1. Elution pattern of cow uterine phosphorylase b from 
AMP-Sepharose column chromatography. For conditions 
see sections 2 and 3. 
phosphorylase b (not shown). Here we used a com- 
mercial preparation of AMP-Sepharose, aproduct 
of the coupling Nd (6-aminohexyl)-AMP to Sepharose. 
The isoelectric point was estimated by electrofocusing 
as in [8]. The p1 of the main peak was at 5.7. This 
compares with pI values of 6.25 and 6.2 for the phos- 
phorylase isozymes from skeletal muscle and liver, 
respectively [8,13]. The PLP content in uterine phos- 
phorylase was estimated by a modified sensitive spec- 
trophotometric method based on determination of
the hydrazone in acid medium after the reaction of 
PIP with 4-nitrophenylhydrazine [ 121. It was caI- 
culated that 200 kg phosphorylase contained of 
-1.95 mol PLP. The mol. wt of the enzyme subunits 
was estimated by SDS gel electrophoresis to be 
-100 000 (not shown). 
The relation between the concentration of AMP 
and the reaction rate revealed acurve of Michaelis- 
Menten type giving a K, of the enzyme for AMP of 
7.3 PM. The reaction mixture contained 5 ng phos- 
phorylaselml, 75 mM Glc-l-P, 1% glycogen and AMP 
from 4-40 PM in 0.1 M maleate buffer (pH 6.5). The 
obtained KtMp value is in contrast o the KfMP 
values for phosphorylase b from skeletal muscle and 
liver, which are 60-62 nM and 75 PM, respectively 
[ 14,151. As seen in fig.2, uterine phosphorylase b 
was inhibited by caffeine. The effect of caffeine con- 
centration on the activity of the uterine enzyme was 
measured at 0.01 mM and 1 mM AMP. The former 
value is comparable with AMP concentration i  the 
uterus [ 161, the latter is the AMP concentration 
employed in the routine determination of the phos- 
phorylase b activity. AMP, as a caffeine analog, pro- 
tects the enzyme against the action of this inhibitor. 
We measured initial rates of the synthetic reac- 
tion of inactive phosphorylase atvarious concentra- 
tions of Glc-I-P in the presence of the following phys- 
iological inhibitors of glycogen phosphorolysis: glu- 
cose, Glc-6-P and ATP. In all cases the curves were 
S-shaped. The cooperativity coefficients, h, were cal- 
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Fig.2. The inhibition of uterine phosphorylase 21 by caffeine 
and the protecting effect of AMP. Assayed at 30°C in 20 mM 
pglycerophosphate buffer, 0.1 M NaF, 1 mM EDTA, 1% 
glycogen and 16 mM Glc-1 -P (pH 6.3). 
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culated graphically by the HiI] method in coordinates 
]Og[T/l(f/,ax- v)] vs log [S]. The values of the Hill 
coefficients were equal to 1.6, 1.7 and 1.9 at 1.5 mM 
Glc-6-P, 10 mM ATP and 25 mM glucose. The So.5 
data for these effecters were 12.8 mM, 13 mM and 
8.7 mM, respectively. Therefore the data obtained 
suggest the existence of a positive allosteric interaction 
of the Glc-I -P binding sites in uterine phosphorylase b.
These data and [2,4,5] demonstrate hat uterine 
phosphorylase b is a dimer with a mol. wt -200 000. 
The conversion of inactive phosphorylase b to the 
active form, phospho~la~ a, was not ac~omp~ied 
by tetramerization. The sedimentation coeffcent of 
the enzyme was calculated to be 8.4 S and ~15.7. 
The protein contained 1 ma1 PLP/lOO kg enzyme 
subunit. Uterine b-form was inactive without AMP 
and had high affmity for this activator with #tMP = 
7.3 PM_ It was not activated by NazS04 alone, though 
activated by this salt in the presence of AMP. Caffeine 
inhibited uterine phosphorylase b. The smooth muscle 
phosphorylase b did not differ from both isozyme III, 
i.e., skeletal muscle phosphorylase, and liver isozyme 
L in its binding affinity for Glc-I-P, its s20,w value, 
subunit mol. wt. and PIP content. Like phosphoryl- 
ases L and III, the uterine enzyme exhibited allosteric 
properties in the presence of some effecters. The 
analyzed protein was different from both isozyme L 
and III in respect o its p1 and KfMP values. Whereas 
skeletal muscle phospho~lase b unde~ent a doubling 
of molecular weight during conversion to the active 
form, the inactive uterine enzyme did not. Uterine 
inactive phosphorylase differs from liver enzyme in 
that it undergoes additional activation by Na,,S04 
only in the presence of AMP. It also differs from liver 
phospho~lase in its Ki characte~stics for glucose and 
ATP (not shown). No significant distinction is to be 
drawn between uterine phosphorylase and isozyme I. 
Homodimer I-I is one of the components of the 
phosphorylase isozyme patterns in mammalian heart 
[17]. Its p1 was found to be 5.6 1131 ~d~~Mp, 
found 9 pM f14]. 
Insignificant variations in uterine and isozyme I
constants are to be accounted for by s 
differences. However, the p1 and KaAM g 
ecies specific 
values for III 
and L isozymes mentioned above stand in marked 
contrast o those for isozyme I. The identity of the 
uterine form with the isozyme I was also supported 
by the data on electrophoretic mobility of the phos- 
phorylase from the rat uterine extract and its inhibi- 
tion by antisera [131. 
Therefore, the forms cited in the literature as brain 
phosphorylase [lS],heart isozyme I [17,19],*fetal 
isozyme [20,21] and uterine phosphorylase hould 
be considered as the same protein species. 
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